CD8A and neoplasm: In contrast, CD8+ tumor-infiltrating lymphocytes (TILs) from either B16-3340 tumors in SFB− mice or B16-EV tumors in SFB+ mice failed to produce these effector molecules (Figure 2c and Extended Data Fig. 2b).